14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days £5.34 £19.02 Tuesday, 7th May 2024 N4P.L stock ended at £0.750. During the day the stock fluctuated 0% from a day low at £0.750 to a day high of £0.750.
90 days £17.30 £19.02
52 weeks £16.32 £20.85

Historical N4 Pharma Plc prices

Date Open High Low Close Volume
Nov 06, 2023 £0.88 £0.88 £0.88 £0.88 0
Nov 03, 2023 £0.87 £0.88 £0.80 £0.88 110 413
Nov 02, 2023 £0.83 £0.87 £0.83 £0.87 104 000
Nov 01, 2023 £0.95 £0.95 £0.87 £0.88 48 170
Oct 31, 2023 £0.87 £0.88 £0.83 £0.88 51 657
Oct 30, 2023 £0.84 £0.85 £0.84 £0.85 105 112
Oct 27, 2023 £0.83 £0.90 £0.83 £0.85 179 400
Oct 26, 2023 £0.85 £0.85 £0.80 £0.85 556 385
Oct 25, 2023 £0.90 £0.95 £0.82 £0.85 5 177 189
Oct 24, 2023 £0.90 £0.95 £0.90 £0.95 418 325
Oct 23, 2023 £1.00 £1.00 £0.90 £0.90 11 538
Oct 20, 2023 £0.90 £0.95 £0.90 £0.95 42 193
Oct 19, 2023 £0.95 £0.95 £0.95 £0.95 0
Oct 18, 2023 £0.95 £0.97 £0.91 £0.95 384 657
Oct 17, 2023 £0.94 £1.02 £0.91 £1.00 807 288
Oct 16, 2023 £0.93 £0.98 £0.93 £0.95 469 231
Oct 13, 2023 £0.99 £0.99 £0.90 £0.99 39 921
Oct 12, 2023 £0.93 £1.00 £0.90 £0.95 24 604
Oct 11, 2023 £1.00 £1.00 £0.90 £0.95 402 552
Oct 10, 2023 £0.90 £1.00 £0.90 £0.95 443 613
Oct 09, 2023 £0.97 £0.97 £0.92 £0.97 233 639
Oct 06, 2023 £1.00 £1.00 £0.91 £0.91 86 656
Oct 05, 2023 £0.91 £0.97 £0.90 £0.97 624 120
Oct 04, 2023 £0.95 £1.00 £0.90 £0.95 3 099 974
Oct 03, 2023 £0.99 £1.00 £0.93 £0.95 6 121 904
Click to get the best stock tips daily for free!

About N4 Pharma Plc

N4 Pharma Plc N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.... N4P.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT